Home / Media Centre / Company News / PJSC SIC 'BCPP' STARTED PRODUCTION OF THE NEW PRODUCT CRATAL FOR CHILDREN

Company News

05.04.2013

PJSC SIC 'BCPP' STARTED PRODUCTION OF THE NEW PRODUCT CRATAL FOR CHILDREN

Therapeutic indications.

It is recommended for the treatment of patients with autonomic disturbances (neurocirculatory and vegetovascular disorders: increased fatigue, emotional lability, insomnia, headache, dizziness).

The instructions for use of the medicinal product